Your shopping cart is currently empty

HDAC-IN-98 is an inhibitor of HDAC1, HDAC2, and HDAC3, with IC₅₀ values of 41.2 nM, 52.5 nM, and 74.3 nM, respectively. HDAC-IN-98 induces H3K9 acetylation, upregulates p21 expression, causes G2/M phase arrest, and induces apoptosis, making it suitable for research on epigenetic regulation in tumors.


| Description | HDAC-IN-98 is an inhibitor of HDAC1, HDAC2, and HDAC3, with IC₅₀ values of 41.2 nM, 52.5 nM, and 74.3 nM, respectively. HDAC-IN-98 induces H3K9 acetylation, upregulates p21 expression, causes G2/M phase arrest, and induces apoptosis, making it suitable for research on epigenetic regulation in tumors. |
| Targets&IC50 | HDAC2:IC₅₀: 42.6 nM, HDAC3:IC₅₀: 51.8 nM, HDAC1:IC₅₀: 37.2 nM |
| In vitro | HDAC-IN-98 (1–4 μM; 48 h) disrupts the cell cycle, induces subG1 accumulation leading to apoptosis in HCT116 cells, and causes G1 phase arrest in HT29/DLD1 cells. [1] HDAC-IN-98 (1 μM; in vitro pretreatment; 48 hours) demonstrated potent antitumor activity in a chicken embryo chorioallantoic (CAM) model of colorectal cancer, independent of p21 status. In the HCT116 p21 wild-type CAM model, HDAC-IN-98 was shown to significantly upregulate p21.[1] |
| Molecular Weight | 415.44 |
| Formula | C24H21N3O4 |
| Smiles | NC1=CC=CC=C1NC(C2=CC=C(CNC(/C=C/C3=CC(OCO4)=C4C=C3)=O)C=C2)=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.